Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificity

Journal of Clinical Investigation

Volumn 115, Issue 8, 2005, Pages 2268-2276

  Suri, Anish ^a   Walters, James J ^a   Gross, Michael L ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; IA ANTIGEN; IA G7 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; DIABETOGENESIS; HUMAN; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ISOLATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; CELL LINE; DIABETES MELLITUS, TYPE 1; HLA-DQ ANTIGENS; HUMANS; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING;

EID: 23644433712     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI25350     Document Type: Article

References (41)

1. Castano, L., and Eisenbarth, G.S. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat [review]. Annu. Rev. Immunol. 8:647-679.
2. Wicker, L.S., Todd, J.A., and Peterson, L.B. 1995. Generic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200.
3. McDevitt, H., Singer, S., and Tisch, R. 1996. The role of MHC class II genes in susceptibility and resistance to type I diabetes mellitus in the NOD mouse. Horm. Metab. Res. 28:287-288.
4. Kikutani, H., and Makino, S. 1992. The murine autoimmune diabetes model: NOD and related strains [review]. Adv. Immunol. 51:285-322.
5. Acha-Orbea, H., and McDevitt, H.O. 1987. The first external domain of the nonobese diabetic mouse class III-A beta chain is unique. Proc. Natl. Acad. Sci. U. S. A. 84:2435-2439.
6. Morel, P.A., Dorman, J.S., Todd, J.A., McDevitt, H.O., and Trucco, M. 1988. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study [erratum 1989, 86:1317]. Proc. Natl. Acad. Sci. U. S. A. 85:8111-8115.
7. Todd, J.A., Bell, J.I., and McDevitt, H.O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:599-604.
8. Abraham, R.S., Kudva, Y.C., Wilson, S.B., Strominger, J.L., and David, C.S. 2000. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes. 49:548-554.
9. Deschamps, I., Beressi, J.P., Khalil, I., Robert, J.J., and Hors, J. 1991. The role of genetic predisposition to type I (insulin-dependent) diabetes mellitus. Ann. Med. 23:427-435.
10. Latek, R.R., et al. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity. 12:699-710.
11. Corper, A.L., et al. 2000. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science. 288:505-511.
12. Lee, K.H., Wucherpfennig, K.W., and Wiley, D.C. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2:501-507.
13. Suri, A., et al. 2002. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J. Immunol. 168:1235-1243.
14. Suri, A., Walters, J.J., Kanagawa, O., Gross, M.L., and Unanue, E.R. 2003. Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: the lack of competition. Proc. Natl. Acad. Sci. U.S.A. 100:5330-5335.
15. Nelson, C.A., Viner, N.J., Young, S.P., Petzold, S.J., and Unanue, E.R. 1996. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak. J. Immunol. 157:755-762.
16. Fremont, D.H., Monnaie, D., Nelson, C.A., Hendrickson, W.A., and Unanue, E.R. 1998. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity. 8:305-317.
17. Chicz, R.M., et al. 1994. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 6:1639-1649.
18. Godkin, A., et al. 1997. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9:905-911.
19. Johansen, B.H., Vartdal, F., Eriksen, J.A., Thorsby, E., and Sollid, L.M. 1996. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8:177-182.
20. Kwok, W.W., Domeier, M.L., Raymond, F.C., Byers, P., and Nepom, G.T. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171-2177.
21. Nepom, B.S., Nepom, G.T., Coleman, M., and Kwok, W.W. 1996. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. U. S. A. 93:7202-7206.
22. Quarsten, H., et al. 1998. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. Int. Immunol. 10:1229-1236.
23. Reizis, B., Altmann, D.M., and Cohen, I.R. 1997. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice. Eur. J. Immunol. 27:2478-2483.
24. Sidney, J., Del Guercio, M.F., Southwood, S., and Sette, A. 2002. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity. J. Immunol. 169:5098-5108.
25. Sato, A.K., Sturniolo, T., Sinigaglia, F., and Stern, L.J. 1999. Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303). Hum. Immunol. 60:1227-1236.
26. Straumfors, A., et al. 1998. A peptide-binding assay for the disease-associated HLA-DQ8 molecule. Scand. J. Immunol. 47:561-567
27. Vartdal, F., et al. 1996. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur. J. Immunol. 26:2764-2772.
28. Verreck, F.A., et al. 1994. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing. Eur. J. Immunol. 24:375-379.
29. Oiso, M., Nishi, T., Ishikawa, T., Nishimura, Y., and Matsushita, S. 1997. Differential binding of peptides substituted at putative C-terminal anchor residue to HLA-DQ8 and DQ9 differing only at beta 57. Hum. Immunol. 52:47-53.
30. Astill, T.P., Ellis, R.J., Arif, S., Tree, T.I., and Peakman, M. 2003. Promiscuous binding of proinsulin peptides to type 1 diabetes-permissive and -protective HLA class II molecules. Diabetologia. 46:496-503.
31. Stratmann, T., et al. 2000. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 165:3214-3225.
32. Nelson, CA., Roof, R.W., McCourt, D.W., and Unanue, E.R. 1992. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc. Natl. Acad. Sci. U. S. A. 89:7380-7383.
33. Engelhard, V.H., Brickner, A.C., and Zarling, A.L. 2002. Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire [review]. Mol. Immunol. 39:127-137.
34. Carrasco-Marin, E., Shimizu, J., Kanagawa, O., and Unanue, E.R. 1996. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450-458.
35. Latek, R.R., and Unanue, E.R. 1999. Mechanisms and consequences of peptide selection by the I-Ak class II molecule. Immunol. Rev. 172:209-228.
36. Tisch, R., and McDevitt, H. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
37. Liu, J., Purdy, L.E., Rabinovitch, S. Jevnikar, A.M., and Elliott, J.F. 1999. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes. 48:469-477.
38. Kelemen, K., et al. 2004. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J. Immunol. 172:3955-3962.
39. Wen, L., Wong, F.S., Sherwin, R., and Mora, C. 2002. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7. J. Immunol. 168:3635-3640.
40. Raju, R., Munn, S.R., Majoribanks, C., and David, C.S. 1998. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7. Transplant. Proc. 30:561.
41. Nelson, C.A., Petzold, S.J., and Unanue, E.R. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. U. S. A. 90:1227-1231.